{
  "docId": "019de075-e061-72f9-baa2-90171b05eced",
  "docSlug": "cdaaa50efb264b4a4093f665bafb20a4",
  "documentTitle": "Absci | Investor Presentation Deck | 111 slides",
  "authorId": "absci",
  "authorName": "Absci",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 107,
  "pageCount": 111,
  "prevPage": 106,
  "nextPage": 108,
  "slideType": "market_sizing",
  "function": "size_opportunity",
  "density": "dense",
  "nDataPoints": 16,
  "notes": "The slide uses a combination of a horizontal bar chart and a data table to quantify the addressable market.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/107",
  "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced",
  "deckJsonHref": "/decks/019de075-e061-72f9-baa2-90171b05eced.json",
  "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-107",
  "components": [
    {
      "bbox": {
        "h": 0.4,
        "w": 0.45,
        "x": 0.05,
        "y": 0.31
      },
      "kind": "chart",
      "text": "Estimated ICI-Resistance Percentage Rates Among Select Oncology Indications",
      "attrs": null,
      "subkind": "bar-horizontal",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a6fd5891-2ec4-4d88-b18e-c19e95dca6dd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.05,
        "y": 0.77
      },
      "kind": "paragraph",
      "text": "Comprehensive profiling of ABS-301's immuno-oncological potential in progress.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "79fe5c82-acaa-48b3-a367-21680df3a279",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.4,
        "x": 0.515,
        "y": 0.77
      },
      "kind": "source-note",
      "text": "1. Siegel et al, CA, 2023, 73 (1), 17-48; 2. Evaluate Pharma; 3-7. Various citations.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a3653e0d-206a-4e15-87da-c5fda0ebf2bb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.45,
        "x": 0.515,
        "y": 0.31
      },
      "kind": "table",
      "text": "Indication, US Estimated New Cases in 2023, Estimated Global Therapeutics Market (2028)",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dffecec1-ec93-4234-b726-77345679a05a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.8,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "title",
      "text": "ABS-301 has a broad potential in immuno-oncology",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ffb8edf2-f635-4b4d-ae38-8f5b8a6b0e04",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}